Business News

Professional Services News

Pieris Pharmaceuticals to Host Full-Year 2017 Investor Call and Corporate Update on March 9, 2018

BOSTON, MA–(Marketwired – February 28, 2018) – Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its [...]

Avalon GloboCare Teams up with Weill Cornell Medicine to Establish Joint Translational Research Initiative in Stem Cell Technology and Regenerative Medicine

FREEHOLD, NJ–(Marketwired – February 28, 2018) – Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies, announced today that the Company [...]

VistaGen Therapeutics to Present at the Cowen and Company 38th Annual Health Care Conference on March 14, 2018

SOUTH SAN FRANCISCO, CA–(Marketwired – February 27, 2018) – VistaGen Therapeutics, Inc. (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation [...]

Oncolytics Biotech(R) to Present REOLYSIN(R) at the 2018 Precision: Breast Cancer World R&D Summit

CALGARY, AB and SAN DIEGO, CA–(Marketwired – February 27, 2018) – Oncolytics Biotech® Inc. (TSX: ONC) (OTCQX: ONCYF), a biotech company developing REOLYSIN®, also known [...]

Cantabio Pharmaceuticals to Present Results from its Tau Protein Targeting Therapeutic Program for the treatment of Alzheimer’s Disease at the Advances in Alzheimer’s and Parkinson’s Therapies, An AAT-AD/PD Focus Meeting in Torino, Italy

SAN FRANCISCO, CA–(Marketwired – February 26, 2018) – Cantabio Pharmaceuticals, Inc. (OTCQB: CTBO), a biopharmaceutical company developing novel disease modifying therapies for [...]

Novoheart Holdings Inc. Announces AGM Results, Receives Governmental Funding to Expand R&D Team, and Reports Second Quarter 2018 Financial Results

VANCOUVER, BRITISH COLUMBIA–(Marketwired – Feb. 26, 2018) - Novoheart Holdings Inc. (“Novoheart” or the “Company“) (TSX VENTURE:NVH) today announced that it [...]

page  20  of  68